| Autor: |
Kovaleva EV; Endocrinology Research Center., Eremkina AK; Endocrinology Research Center., Krupinova JA; Endocrinology Research Center., Mirnaya SS; Network of Family Medical Centers No. 1., Kim IV; Endocrinology Research Center., Kuznetzov NS; Endocrinology Research Center., Andreeva EN; Endocrinology Research Center., Karonova TL; National Medical Research Center. V. A. Almazova., Kryukova IV; Moscow Regional Research Clinical Institute. M.F. Vladimirskogo., Mudunov AM; National Medical Research Center of Oncology named after V.I. N.N. Blokhin., Sleptcov IV; Clinic of high medical technologies. N.I. Pirogov St. Petersburg State University., Melnichenko GA; Endocrinology Research Center., Mokrysheva NG; Endocrinology Research Center., Dedov II; Endocrinology Research Center. |
| Abstrakt: |
Hypoparathyroidism is a rare disorder characterized by the absent or inappropriately decreased serum parathyroid hormone in the parathyroid glands, which is accompanied by impaired calcium-phosphorus metabolism.The main etiology of hypoparathyroidism remains damage or removal of the parathyroid glands during neck surgery. In view of the incidence of thyroid cancer, primary hyperparathyroidism and other pathologies of the neck organs, which radical treatment can lead to the parathyroid gland impairment, an increased number of patients with hypoparathyroidism is expected. Autoimmune hypoparathyroidism is the second most common form of the disease, usually occurring as part of type 1 autoimmune polyglandular syndrome. Autoimmune hypoparathyroidism usually occurs in childhood and is characterized by a severe course of the disease, especially in the case of concomitant malabsorption syndrome.Chronic hypoparathyroidism of any etiology requires lifelong multicomponent therapy, as well as careful monitoring and an individual approach to choose the optimal treatment strategy. In the absence of adequate follow-up, the risks of long-term complications significantly increase, particularly in the renal, cardiovascular systems; in the soft tissues and in the brain, it could lead to visual disturbances; pathology of the musculoskeletal system with a decreased bone remodeling and a potential risk of fractures, as well as to the neurocognitive disorders and an impaired health-related quality of life.Timely diagnosis, rational medical therapy and management strategy may reduce the risks of short-term and long-term complications, frequency of hospitalizations and disability of patients, as well as improve the prognosis.This review covers the main issues of Russian guidelines for the management of chronic hypoparathyroidism, approved in 2021, including laboratory and instrumental evaluation, treatment approaches and follow-up. This guidelines also include the recommendations for special groups of patients: with acute hypocalcemia, hypoparathyroidism during pregnancy. |
